NASDAQ · Medical - Instruments & Supplies

STAA (STAA) Stock

$22.95 -1.84% NASDAQ: STAA Healthcare

Valuation

MetricValue
Price$22.95
Market Cap$1.14B
P/E Ratio28.95
P/B Ratio4.04
P/S Ratio4.90
EPS (TTM)$0.77
52-Week High$35.87
52-Week Low$15.59
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-5.99%
ROA0.88%
ROCE-13.33%
Gross Margin76.43%
Operating Margin-1.72%
Net Margin-7.24%
Debt/Equity0.11
Current Ratio4.52

Annual Financials (USD)

Metric20212022202320242025
Revenue$230.0M$284.0M$322.0M$314.0M$239.0M
Operating Profit$33.0M$44.0M$28.0M$-13.0M$-46.0M
Net Profit$28.0M$40.0M$21.0M$-20.0M$-80.0M
EPS$0.50$0.80$0.43$-0.41$-1.62
Op Margin14.5%15.4%8.7%-4.0%-19.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$346.0M$419.0M$489.0M$510.0M$462.0M
Total Liabilities$87.0M$83.0M$103.0M$112.0M$117.0M
Cash$200.0M$86.0M$183.0M$144.0M$153.0M
Borrowings$32.0M$31.0M$36.0M$39.0M$38.0M

Latest News

STAA: Lowering target price to $21.00 Argus Research · Jul 22, 2026 STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know StockStory · Jul 17, 2026 3 Unprofitable Stocks with Questionable Fundamentals StockStory · Jul 17, 2026 Staar Surgical China Turnaround Continues to Boost Confidence, Wedbush Says MT Newswires · Jul 17, 2026 STAAR Surgical Reports Higher Q2 Preliminary Net Sales MT Newswires · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$44.0M$36.0M$15.0M$16.0M$-34.0M
Investing Cash Flow$-27.0M$-174.0M$56.0M$-83.0M$41.0M
Financing Cash Flow$19.0M$8.0M$8.0M$6.0M$-8.0M
Net Cash Flow$47.0M$-113.0M$97.0M$-39.0M$9.0M
Free Cash Flow$30.0M$18.0M$-4.0M$-8.0M$-40.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.76
EV / EBITDA88.62
FCF Yield-3.87%
Quick Ratio4.31
Interest Coverage—
Return 1Y25.40%
Return 3Y-58.09%
Return 5Y-78.79%

Ownership

Insiders Held0.78%
Institutions Held113.72%
Institutions Float Held114.62%
Institutional HolderSharesReport Date
Broadwood Capital, Inc.16,123,8422026-03-31
Blackrock Inc.6,666,1182026-03-31
Yunqi Capital Ltd3,257,1302026-03-31
Madison Avenue Partners, LP2,441,6782026-03-31
Vanguard Portfolio Management LLC2,123,5892026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AZTA $29.88 +6.22% -15.22 $1.38B 0.00%
BBNX $15.90 +12.69% -6.53 $715.34M 0.00%
BLFS $32.15 +2.78% -96.00 $1.57B 0.00%
KMTS $23.99 +5.08% -3.85 $1.41B 0.00%
NVCR $16.39 +4.46% -15.27 $1.91B 0.00%

About STAA

STAA is led by CEO Warren Foust, employs 1,157 people, headquartered in US, publicly traded since 1992.

STAA stock trades at $22.95 with a market capitalization of $1.14B. The stock is valued at a price-to-earnings (P/E) ratio of 28.95, price-to-book of 4.04, price-to-sales of 4.90. Over the past 52 weeks the stock has ranged between $15.59 and $35.87, and currently trades 36.0% below its 52-week high.

On profitability, STAA generates a return on equity (ROE) of -5.99%, return on capital employed of -13.33%, an operating margin of -1.72%, a net profit margin of -7.24%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides